Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Dec;30(3):700-8.
doi: 10.1128/iai.30.3.700-708.1980.

Immediate loss of cell-mediated immunity to murine cytomegalovirus upon treatment with immunosuppressive agents

Immediate loss of cell-mediated immunity to murine cytomegalovirus upon treatment with immunosuppressive agents

D M Mattsson et al. Infect Immun. 1980 Dec.

Abstract

Splenic lymphocytes from cytomegalovirus-infected mice lost their in vitro proliferative responses to cytomegalovirus antigen within 3 h after in vivo treatment with antilymphocyte globulin and prednisolone. The response was inhibited when the agents were administered separately or together, and inhibition persisted through a 2-week course of immunosuppression. Circulating specific antibodies were depressed by multiple injections of antilymphocyte globulin alone or with prednisolone, but not by prednisolone alone. Mitogen-induced blast transformation was immediately depressed by immunosuppression with both agents. Although the response to lipopolysaccharide returned briefly, it declined with continuing treatment. Cytomegalovirus infection augmented the depressive effect of immunosuppression on the lipopolysaccharide proliferative response. Prednisolone treatment of infected animals did not affect the concanavalin A response, and lipopolysaccharide stimulation decreased more slowly and to a lesser extent than it did in mice treated with antilymphocyte globulin or both agents. Loss of specific cell-mediated immunity and simultaneous depression of humoral immunity indicated that immunosuppression immediately created an inability to respond to an active cytomegalovirus infection.

PubMed Disclaimer

References

    1. Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed
    1. Ann Surg. 1972 Feb;175(2):257-9 - PubMed
    1. Adv Immunol. 1973;16:123-84 - PubMed
    1. Ann Surg. 1974 Oct;180(4):623-34 - PubMed
    1. Cell Immunol. 1974 Mar 30;11(1-3):478-83 - PubMed

Publication types